Selvita S.A. (SLV) - Net Assets
Based on the latest financial reports, Selvita S.A. (SLV) has net assets worth zł317.10 Million PLN (≈ $87.27 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (zł584.11 Million ≈ $160.76 Million USD) and total liabilities (zł267.02 Million ≈ $73.49 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Selvita S.A. (SLV) strategic asset index to assess the company's strategic physical and investment asset allocation.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | zł317.10 Million |
| % of Total Assets | 54.29% |
| Annual Growth Rate | 21.24% |
| 5-Year Change | 56.52% |
| 10-Year Change | 477.49% |
| Growth Volatility | 65.88 |
Selvita S.A. - Net Assets Trend (2015–2025)
This chart illustrates how Selvita S.A.'s net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see SLV market cap.
Annual Net Assets for Selvita S.A. (2015–2025)
The table below shows the annual net assets of Selvita S.A. from 2015 to 2025. Also explore Selvita S.A. (SLV) net asset momentum to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | zł321.73 Million ≈ $88.54 Million |
-0.05% |
| 2024-12-31 | zł321.88 Million ≈ $88.59 Million |
-1.59% |
| 2023-12-31 | zł327.07 Million ≈ $90.01 Million |
+19.74% |
| 2022-12-31 | zł273.16 Million ≈ $75.18 Million |
+32.89% |
| 2021-12-31 | zł205.55 Million ≈ $56.57 Million |
+34.65% |
| 2020-12-31 | zł152.66 Million ≈ $42.01 Million |
+220.33% |
| 2019-12-31 | zł47.66 Million ≈ $13.12 Million |
-3.11% |
| 2018-12-31 | zł49.19 Million ≈ $13.54 Million |
+31.73% |
| 2017-12-31 | zł37.34 Million ≈ $10.28 Million |
-32.97% |
| 2016-12-31 | zł55.71 Million ≈ $15.33 Million |
+18.84% |
| 2015-12-31 | zł46.88 Million ≈ $12.90 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Selvita S.A.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 3734.9% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | zł133.41 Million | 41.47% |
| Common Stock | zł14.68 Million | 4.56% |
| Other Comprehensive Income | zł87.18 Million | 27.10% |
| Other Components | zł86.45 Million | 26.87% |
| Total Equity | zł321.73 Million | 100.00% |
Selvita S.A. Competitors by Market Cap
The table below lists competitors of Selvita S.A. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Ajiya Bhd
KLSE:7609
|
$134.90 Million |
|
HAPPY BELLY FOOD GRO.INC.
F:W3J
|
$134.93 Million |
|
ANJI Technology Co. Ltd
TW:6477
|
$134.94 Million |
|
Bhartiya International Limited
NSE:BIL
|
$135.04 Million |
|
Banco Alfa de Investimento S.A
SA:BRIV3
|
$134.78 Million |
|
Endomines Finland Oyj
HE:PAMPALO
|
$134.72 Million |
|
DMS Propertindo Tbk PT
JK:KOTA
|
$134.72 Million |
|
Currency Exchange International Corp
TO:CXI
|
$134.69 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Selvita S.A.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 321,877,000 to 321,730,000, a change of -147,000 (-0.0%).
- Net income of 813,000 contributed positively to equity growth.
- Other comprehensive income decreased equity by 959,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | zł813.00K | +0.25% |
| Other Comprehensive Income | zł-959.00K | -0.3% |
| Other Changes | zł-1.00K | -0.0% |
| Total Change | zł- | -0.05% |
Book Value vs Market Value Analysis
This analysis compares Selvita S.A.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.52x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 9.25x to 1.52x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2015-12-31 | zł2.89 | zł26.70 | x |
| 2016-12-31 | zł3.44 | zł26.70 | x |
| 2017-12-31 | zł2.21 | zł26.70 | x |
| 2018-12-31 | zł2.87 | zł26.70 | x |
| 2019-12-31 | zł2.77 | zł26.70 | x |
| 2020-12-31 | zł8.56 | zł26.70 | x |
| 2021-12-31 | zł10.73 | zł26.70 | x |
| 2022-12-31 | zł14.28 | zł26.70 | x |
| 2023-12-31 | zł17.82 | zł26.70 | x |
| 2024-12-31 | zł17.54 | zł26.70 | x |
| 2025-12-31 | zł17.53 | zł26.70 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Selvita S.A. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.25%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.22%
- • Asset Turnover: 0.61x
- • Equity Multiplier: 1.86x
- Recent ROE (0.25%) is below the historical average (10.52%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2015 | 13.50% | 15.28% | 0.63x | 1.40x | zł1.63 Million |
| 2016 | 4.91% | 5.65% | 0.54x | 1.61x | zł-2.82 Million |
| 2017 | 11.01% | 7.19% | 1.14x | 1.34x | zł361.58K |
| 2018 | 22.70% | 14.85% | 0.97x | 1.57x | zł5.87 Million |
| 2019 | 12.49% | 18.14% | 0.33x | 2.06x | zł1.10 Million |
| 2020 | 12.22% | 13.10% | 0.63x | 1.49x | zł3.27 Million |
| 2021 | 7.57% | 4.79% | 0.67x | 2.37x | zł-4.79 Million |
| 2022 | 11.56% | 8.40% | 0.62x | 2.23x | zł4.09 Million |
| 2023 | 21.36% | 20.15% | 0.54x | 1.95x | zł37.17 Million |
| 2024 | -1.89% | -1.78% | 0.53x | 1.99x | zł-38.29 Million |
| 2025 | 0.25% | 0.22% | 0.61x | 1.86x | zł-31.36 Million |
Industry Comparison
This section compares Selvita S.A.'s net assets metrics with peer companies in the Diagnostics & Research industry.
Industry Context
- Industry: Diagnostics & Research
- Average net assets among peers: $35,391,914
- Average return on equity (ROE) among peers: 0.55%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Selvita S.A. (SLV) | zł317.10 Million | 13.50% | 0.84x | $134.85 Million |
| Biomaxima (BMX) | $16.83 Million | 7.29% | 0.39x | $11.75 Million |
| Scope Fluidics SA (SCP) | $6.70 Million | -9.52% | 0.41x | $93.33 Million |
| Voxel S.A. (VOX) | $82.64 Million | 3.88% | 1.03x | $407.56 Million |
About Selvita S.A.
Selvita S.A. provides drug discovery, drug development, and contract testing services in Poland. The company offers computer-aided drug design and artificial intelligence solutions, including structure-based drug design, virtual screening, and bioinformatics; medicinal and synthetic, analytical, and solid state chemistry, as well as process chemistry and scale up, and compound management and libr… Read more